Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis

被引：30
|
作者：
Daumerie, C
Vynckier, S
Caussin, J
Jadoul, M
Squifflet, JP
dePatoul, N
Wambersie, A
机构：
[1] CLIN UNIV ST LUC,DEPT RADIOTHERAPY,B-1200 BRUSSELS,BELGIUM
[2] CLIN UNIV ST LUC,DEPT RADIAT PROTECT,B-1200 BRUSSELS,BELGIUM
[3] CLIN UNIV ST LUC,DEPT NEPHROL,B-1200 BRUSSELS,BELGIUM
[4] CLIN UNIV ST LUC,DEPT ENDOCRINE SURG,B-1200 BRUSSELS,BELGIUM
来源：
THYROID | 1996年 / 6卷 / 04期
关键词：
D O I：
10.1089/thy.1996.6.301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
To deliver optimal radioiodine activity in hemodialyzed patients with thyroid carcinoma, the behavior of radioiodine was followed during six treatments. During hemodialysis, blood activity decreases with a half-life of 3.4 +/- 0.5, (1SD) h. The whole body dose was calculated from the total activity determined during 10 days after I-131 administration. A reasonable strategy may consist in delivering 25% of the currently prescribed activity (925 MBq-25 mCi) and to perform the first dialysis session after 24 h to reduce total body irradiation.
引用
收藏
页码：301 / 304
页数：4
相关论文
共 50 条
  • [41] Ablative radioiodine treatment in children with differentiated thyroid carcinoma - own experience
    Czepczynski, R.
    Rabska-Pietrzak, B.
    Ziemnicka, K.
    Czarnywojtek, A.
    Baczyk, M.
    Niedziela, M.
    Sowinski, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S196 - S196
  • [42] MYELODYSPLASTIC SYNDROME FOLLOWING TREATMENT OF A DIFFERENTIATED THYROID-CARCINOMA WITH RADIOIODINE
    PASCUAL, LG
    SIMO, R
    MESA, J
    GALOFRE, P
    REVISTA CLINICA ESPANOLA, 1992, 191 (03): : 169 - 170
  • [43] BLOOD-COUNT CHANGES FOR RADIOIODINE TREATMENT IN THYROID-CARCINOMA
    GRUNWALD, F
    SCHOMBURG, A
    MENZEL, C
    STEINECKER, S
    SPATH, G
    BOCKISCH, A
    FIMMERS, R
    HOTZE, AL
    BIERSACK, HJ
    MEDIZINISCHE KLINIK, 1994, 89 (10) : 522 - 528
  • [44] Chronic myeloid leukemia following radioiodine treatment for papillary carcinoma of thyroid
    Gupta, Gopila
    Aggarwal, Mukul
    Juneja, Richa
    Seth, Tulika
    INDIAN JOURNAL OF CANCER, 2022, 59 (03) : 436 - 437
  • [45] Improved prediction of therapeutic absorbed doses of radioiodine in the treatment of thyroid carcinoma
    Hermanská, J
    Kárny, M
    Zimák, J
    Jirsa, L
    Sámal, M
    Vlcek, P
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (07) : 1084 - 1090
  • [46] RADIOIODINE AS AN ADJUNCT TO THE SURGICAL-TREATMENT OF MEDULLARY-THYROID CARCINOMA
    DEFTOS, LJ
    STEIN, MF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (05): : 967 - 968
  • [47] TRANSFORMATION OF A LOW GRADE PAPILLARY CARCINOMA OF THE THYROID TO AN ANAPLASTIC CARCINOMA AFTER TREATMENT WITH RADIOIODINE
    CRILE, G
    WILSON, DH
    SURGERY GYNECOLOGY & OBSTETRICS, 1959, 108 (03): : 357 - 360
  • [48] Treatment of advanced differentiated thyroid carcinoma with high activity radioiodine therapy
    Haq, MS
    McCready, RV
    Harmer, CL
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (08) : 799 - 805
  • [49] THE ROLE OF RADIOIODINE IN THE TREATMENT OF CARCINOMA OF THE THYROID - DAVIDSON,MACKENZIE MEMORIAL LECTURE
    HILTON, G
    BRITISH JOURNAL OF RADIOLOGY, 1956, 29 (342): : 297 - 310
  • [50] THYROID-NODULES IN FEMALE UREMIC PATIENTS ON MAINTENANCE HEMODIALYSIS
    MIKI, H
    OSHIMO, K
    INOUE, H
    KAWANO, M
    TANAKA, K
    KOMAKI, K
    UYAMA, T
    KAWAUCHI, M
    MINAKUCHI, J
    KAWASHIMA, S
    MONDEN, Y
    JOURNAL OF SURGICAL ONCOLOGY, 1993, 54 (04) : 216 - 218
12345